ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

D Craig Allred et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.